Poolbeg Pharma (POLB) has secured a South Korean patent covering POLB 001 and the use of p38 MAP kinase inhibitors to prevent ...
MedPal AI (MPAL) said September trading delivered further strong growth, taking its annualised revenue run rate to more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results